F.D.A. Authorizes a New Covid Drug to Protect High-Risk Peoplenews2024-03-25T21:34:39+00:00March 25th, 2024|The New York Times|
RSV Vaccines: What to Know For Babies, Pregnant Women and Older Adultsnews2023-08-21T09:00:31+00:00August 21st, 2023|The New York Times|
New Covid Variants Are Circulating. Here’s What to Know.news2022-11-04T14:33:26+00:00November 4th, 2022|The New York Times|
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drugnews2022-04-06T18:43:00+00:00April 6th, 2022|The New York Times|
Antibody Drug to Protect the Vulnerable From Covid Goes Unusednews2022-03-06T08:00:09+00:00March 6th, 2022|The New York Times|
F.D.A. Clears Monoclonal Antibody Drug From Eli Lillynews2022-02-11T22:51:51+00:00February 11th, 2022|The New York Times|
Covid Treatments Including Paxlovid Are Rationed as Cases Spikenews2022-01-06T22:11:24+00:00January 6th, 2022|The New York Times|
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problemsnews2021-12-08T23:03:55+00:00December 8th, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
